Literature DB >> 8393248

Nucleotide sequence of the splice junction of feline leukemia virus envelope mRNA.

M D Papenhausen1, J Overbaugh.   

Abstract

The splice donor and acceptor sequences for the subgenomic envelope messenger RNA of feline leukemia virus (FeLV) were determined. The splice junction was characterized for viral mRNA from a prototype subgroup A FelV and an immunodeficiency-inducing FeLV variant. Thirty-seven of 38 partial envelope cDNAs, cloned after PCR amplification from T cells infected with either virus, utilized the same splice donor and acceptor sites to generate a mRNA that would be predicted to encode envelope protein. One novel cDNA, which could also code for envelope protein, was generated from a cryptic splice acceptor 109 nucleotides downstream of the normal junction. No additional subgenomic FeLV gene products were detected using reverse transcription and polymerase chain reaction amplification of FeLV sequences from chronically infected cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393248     DOI: 10.1006/viro.1993.1434

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

1.  Sequence comparison of three infectious molecular clones of RD-114 virus.

Authors:  Sayumi Shimode; Rokusuke Yoshikawa; Shigeki Hoshino; Yuki Nakaya; Shoichi Sakaguchi; Takeshi Kobayashi; Takayuki Miyazawa
Journal:  Virus Genes       Date:  2012-05-26       Impact factor: 2.332

2.  Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma.

Authors:  J L Rohn; A S Lauring; M L Linenberger; J Overbaugh
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Generation and role of defective proviruses in cytopathic feline leukemia virus (FeLV-FAIDS) infections.

Authors:  C M de Noronha; T A Reinhart; J I Mullins
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

Review 4.  Applications of DNA amplification techniques in veterinary diagnostics.

Authors:  M Pfeffer; M Wiedmann; C A Batt
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.